Blog

»  Posts By   Pharmacy Law 

Frier Levitt Helps Pharmacy Reverse PBM Termination

Frier Levitt recently reversed a PBM's decision to terminate a pharmacy due to alleged drug invoice shortage discrepancies. The pharmacy was terminated due to the results of a PBM's pre-credentialing audit that failed to take into account a variety of purchases made during and prior to the audit period. The PBM also failed to take into account an inventory that was purchased from the previous owner of the pharmacy. Using...

Frier Levitt Negotiates Access to PBM Network for Previously Denied Pharmacy

Frier Levitt recently negotiated a contract with a PBM network for a pharmacy that had been denied entry on several previous occasions. The pharmacy had applied for a contract numerous times and was denied for various reasons for more than a year, eventually seeking legal assistance from Frier Levitt. Frier Levitt intervened and through application of in-depth knowledge of legal requirements and the PBM application process, assisted the pharmacy to...

Frier Levitt Recovers Over $300K in GER Withholdings From PSAO

Frier Levitt recently recovered over $300K held in reserve from a Pharmacy Services Administrative Organization (PSAO), which withheld the funds to due to Generic Effective Rate (GER) adjustments for the calendar year 2018. This is another major win for an independent pharmacy that suffered grave financial harm. Many pharmacies have begun receiving notices of GER adjustments, ranging from thousands to millions of dollars, without having an opportunity to examine any...

Drug Return Company Ordered to Pay $94 Million in Restitution and $15 Million in Fines for Refund Scheme

Earlier this month, a Pennsylvania federal judge ordered Devos Ltd., a drug return company, to pay over $94 million in restitution and $15 million in fines for failing to channel refunds back to customers and keeping the money for itself. Devos, which does business as Guaranteed Returns, offers middleman services to pharmacies and government agencies who are looking to take advantage of buy-back refunds from drug makers. Instead of issuing...

UPDATE: NYC Transit Authority Files Motion for Extension in Lawsuit Against Express Scripts

On July 12, 2019, the New York City Transit Authority (NYCTA) filed a Motion to extend the deadline to file its brief in opposition to Express Scripts' Motion to Dismiss the NYCTA's Complaint, or alternatively, to file an Amended Complaint. Subsequently, the NYCTA's Motion was granted by the Court and the NYCTA will now have until July 30, 2019 to file an opposition brief or to file an amended version...